Spire Wealth Management’s Anixa Biosciences ANIX Stock Holding History

Spire Wealth Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,500	Closed	-$11K	–	2478
2022 Q4	$11K	Sell	2,500 -12,000	-83%	-$57.7K	﹤0.01%	1563
2022 Q3	$71K	Hold	14,500	–	–	﹤0.01%	822
2022 Q2	$44K	Hold	14,500	–	–	﹤0.01%	1338
2022 Q1	$40K	Hold	14,500	–	–	﹤0.01%	1525
2021 Q4	$43K	Hold	14,500	–	–	﹤0.01%	1795
2021 Q3	$69K	Sell	14,500 -3,000	-17%	-$13.5K	﹤0.01%	1341
2021 Q2	$68K	Sell	17,500 -6,800	-28%	-$29K	﹤0.01%	1350
2021 Q1	$114K	Buy	+24,300	New	+$116K	﹤0.01%	1346

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return